Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?

de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L.

Cancer. 2008 Apr 15;112(8):1672-8. doi: 10.1002/cncr.23368.

2.
3.

The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.

Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.

Eur J Surg Oncol. 2006 Jun;32(5):502-6. Epub 2006 Mar 29.

PMID:
16569492
4.

Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.

Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH.

Ann Surg Oncol. 2009 Jan;16(1):113-20. doi: 10.1245/s10434-008-0121-x. Epub 2008 Oct 23.

PMID:
18949520
6.

Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.

Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A.

Breast J. 2006 Jul-Aug;12(4):294-301.

PMID:
16848838
7.

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS 3rd.

J Clin Oncol. 2008 Apr 10;26(11):1803-9. doi: 10.1200/JCO.2007.12.6425. Epub 2008 Mar 10.

PMID:
18332473
8.

Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.

Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP.

Ann Surg Oncol. 2006 Jun;13(6):783-7. Epub 2006 Apr 12.

PMID:
16604475
9.

Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma.

Apple SK, Moatamed NA, Finck RH, Sullivan PS.

Breast. 2010 Oct;19(5):360-4. doi: 10.1016/j.breast.2010.02.010. Epub 2010 Mar 27.

PMID:
20347308
10.

The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.

Fukagawa T, Sasako M, Shimoda T, Sano T, Katai H, Saka M, Mann GB, Karpeh M, Coit DG, Brennan MF.

Ann Surg Oncol. 2009 Mar;16(3):609-13. doi: 10.1245/s10434-008-0290-7. Epub 2009 Jan 10.

PMID:
19137375
11.

The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung.

Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, McKenna RJ.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):551-7.

12.

Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.

Rescigno J, Zampell JC, Axelrod D.

Ann Surg Oncol. 2009 Mar;16(3):687-96. doi: 10.1245/s10434-008-0195-5. Epub 2008 Dec 20.

PMID:
19101768
13.

Impact of micrometastases in the sentinel node of patients with invasive breast cancer.

Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, Giuliano AE.

J Clin Oncol. 2009 Oct 1;27(28):4679-84. doi: 10.1200/JCO.2008.19.0686. Epub 2009 Aug 31.

PMID:
19720928
14.

Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.

Montagna E, Viale G, Rotmensz N, Maisonneuve P, Galimberti V, Luini A, Intra M, Veronesi P, Mazzarol G, Pruneri G, Renne G, Torrisi R, Cardillo A, Cancello G, Goldhirsch A, Colleoni M.

Breast Cancer Res Treat. 2009 Nov;118(2):385-94. doi: 10.1007/s10549-009-0446-6. Epub 2009 Jun 27.

PMID:
19562480
15.

The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.

Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM.

Eur J Surg Oncol. 2005 Jun;31(5):500-5.

PMID:
15922886
16.

Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.

van Deurzen CH, Cserni G, Bianchi S, Vezzosi V, Arisio R, Wesseling J, Asslaber M, Foschini MP, Sapino A, Castellano I, Callagy G, Faverly D, Martin-Martinez MD, Quinn C, Amendoeira I, Kulka J, Reiner-Concin A, Cordoba A, Seldenrijk CA, van Diest PJ.

J Clin Oncol. 2010 Feb 20;28(6):999-1004. doi: 10.1200/JCO.2009.22.0723. Epub 2010 Jan 19.

PMID:
20085942
17.

Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.

Kilbride KE, Lee MC, Nees AV, Cimmino VM, Diehl KM, Sabel MS, Hayes DF, Schott AF, Kleer CG, Chang AE, Newman LA.

Ann Surg Oncol. 2008 Nov;15(11):3252-8. doi: 10.1245/s10434-008-0136-3. Epub 2008 Sep 11.

PMID:
18784961
18.

Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.

Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, Ferretti S, Frasson C, Zanella C, Ghisellini S, Ambrogi F, Antolini L, Piantelli M, Iacobelli S, Marubini E, Alberti S, Nenci I.

Clin Cancer Res. 2006 Nov 15;12(22):6696-701.

19.

Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.

Hulvat M, Rajan P, Rajan E, Sarker S, Schermer C, Aranha G, Yao K.

Surgery. 2008 Oct;144(4):518-24; discussion 524. doi: 10.1016/j.surg.2008.06.006.

PMID:
18847634
20.

Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.

Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M.

Breast J. 2008 Nov-Dec;14(6):551-5. doi: 10.1111/j.1524-4741.2008.00646.x. Epub 2008 Oct 13.

PMID:
19000054

Supplemental Content

Support Center